Federation des caisses Desjardins du Quebec
Position in ANIP — Ani Pharmaceuticals Inc
CIK 2022297
LEVIS, A8
Position in ANIP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,610,301
+$539,386 QoQ
Shares Held
31,533
+17.1% QoQ
Ownership
0.137%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#98
of 305 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Federation des caisses Desjardins du Quebec holds $38,102,659 across 31 Drug Manufacturers - Specialty & Generic names. ANIP ranks #5 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
317,729 | $10,764,656 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
11,689 | $6,333,449 | |
| 3 | ZTS |
Zoetis Inc.
|
85,213 | $6,123,404 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
23,904 | $4,028,778 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
This page
|
31,533 | $2,610,301 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
496,836 | $2,449,401 | |
| 7 | VTRS |
Viatris Inc
|
104,424 | $1,658,251 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
62,505 | $1,538,247 |
All Filings in ANIP
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,610,301 | 31,533 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,070,915 | 26,930 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,109,525 | 39,391 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $3,587,972 | 39,170 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,053,743 | 31,475 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,625,210 | 24,275 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,163,644 | 21,050 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,166,353 | 19,550 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,244,944 | 19,550 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,462,099 | 21,150 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,166,211 | 21,150 | Shares | Defined | 2024-08-15 | |
| 2023-09-30 | $1,227,969 | 21,150 | Shares | Defined | 2024-08-15 | |
| 2023-06-30 | $966,248 | 17,950 | Shares | Defined | 2024-08-15 | |
| 2023-03-31 | $712,974 | 17,950 | Shares | Defined | 2024-08-15 | |
| 2022-09-30 | $572,092 | 17,800 | Shares | Defined | 2024-08-15 | |
| 2022-06-30 | $474,720 | 16,000 | Shares | Defined | 2024-08-15 | |
| 2022-03-31 | $449,760 | 16,000 | Shares | Defined | 2024-08-15 | |
| 2021-12-31 | $737,280 | 16,000 | Shares | Defined | 2024-08-30 | |
| 2021-09-30 | $169,055 | 5,151 | Shares | Defined | 2024-08-30 | |
| 2020-09-30 | $1,095,958 | 38,850 | Shares | Defined | 2024-08-30 | |
| 2020-06-30 | $1,256,409 | 38,850 | Shares | Defined | 2024-08-30 | |
| 2020-03-31 | $1,413,678 | 34,700 | Shares | Defined | 2024-08-30 | |
| No filing history on record for this holder in this stock. | ||||||